Freeline Therapeutics Holdings plc Increase (Decrease) in Other Noncurrent Assets
Freeline Therapeutics Holdings plc reported Increase (Decrease) in Other Noncurrent Assets of $384.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2023-12-01
- Freeline Therapeutics Holdings plc increase (decrease) in other noncurrent assets for the quarter ending 2022-12-31 was $222.00K.
- Freeline Therapeutics Holdings plc increase (decrease) in other noncurrent assets for the quarter ending 2022-09-30 was -$5.00K.
- Freeline Therapeutics Holdings plc increase (decrease) in other noncurrent assets for the quarter ending 2022-06-30 was -$141.00K, a 113.81% decline year-over-year.
- Freeline Therapeutics Holdings plc increase (decrease) in other noncurrent assets for the quarter ending 2022-03-31 was $308.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $222.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $217.00K derived: sum of 2 quarters · filed 2023-12-01 | $76.00K derived: sum of 3 quarters · filed 2023-12-01 | $384.00K 20-F · filed 2023-04-04 |
| 2022-09-30 | -$5.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | -$146.00K derived: sum of 2 quarters · filed 2023-12-01 | $162.00K 6-K · filed 2023-12-01 | -$82.00K derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-06-30 | -$141.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $167.00K 6-K · filed 2023-08-15 | -$77.00K derived: sum of 3 quarters · filed 2023-08-15 | -$648.00K derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | $308.00K 6-K · filed 2023-05-30 | $64.00K derived: sum of 2 quarters · filed 2023-05-30 | -$507.00K derived: sum of 3 quarters · filed 2023-05-30 | $514.00K derived: sum of 4 quarters · filed 2023-05-30 |
| 2021-12-31 | -$244.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | -$815.00K derived: sum of 2 quarters · filed 2023-04-04 | $206.00K derived: sum of 3 quarters · filed 2023-04-04 | -$9.00K 20-F · filed 2023-04-04 |
| 2021-09-30 | -$571.00K derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | $450.00K derived: sum of 2 quarters · filed 2022-11-15 | $235.00K 6-K · filed 2022-11-15 | $243.00K derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-06-30 | $1.02M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $806.00K 6-K · filed 2022-08-09 | $814.00K derived: sum of 3 quarters · filed 2023-04-04 | $859.00K derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-03-31 | -$215.00K 6-K · filed 2022-05-10 | -$207.00K derived: sum of 2 quarters · filed 2023-04-04 | -$162.00K derived: sum of 3 quarters · filed 2023-04-04 | -$320.00K derived: sum of 4 quarters · filed 2023-04-04 |
| 2020-12-31 | $8.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $53.00K derived: sum of 2 quarters · filed 2023-04-04 | -$105.00K derived: sum of 3 quarters · filed 2023-04-04 | -$104.00K 20-F · filed 2023-04-04 |
| 2020-09-30 | $45.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | -$113.00K derived: sum of 2 quarters · filed 2021-11-09 | -$112.00K 6-K · filed 2021-11-09 | |
| 2020-06-30 | -$158.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16 | -$157.00K 6-K · filed 2021-08-16 | ||
| 2020-03-31 | $1.00K 6-K · filed 2021-05-17 | |||
| 2019-12-31 | $160.00K 20-F · filed 2022-03-31 |